HCW Biologics special shareholder meeting fails to reach quorum
HCWB•HCW Biologics adjourned its November 17 special stockholder meeting without conducting business or voting on a proposal covering up to 618,682 shares. The proposal is scheduled to return for approval at a January 26, 2027, meeting.
1. Meeting adjourned
HCW Biologics adjourned its November 17, 2026, special stockholder meeting without conducting business. No vote was taken on issuing up to 618,682 common shares upon exercise of warrants priced at $2.585 per share, issued in a private placement completed July 29, 2026. The proposal will return for stockholder approval at a January 26, 2027, special meeting; another pending proposal concerns warrants from a private placement closed September 23, 2026.




